Century Therapeutics (IPSC) EBT Margin (2022 - 2025)

Century Therapeutics (IPSC) reported EBT Margin of 70.13% for Q1 2025, up 335212.0% year-over-year from N/an in Q1 2024, and up 108.53% quarter-over-quarter from 821.88% in Q4 2024.

Century Therapeutics (IPSC) EBT Margin (2022 - 2025) Analysis & Trends

Century Therapeutics (IPSC) has 4 years of EBT Margin data on file, last reported at 70.13% in Q1 2025.

  • EBT Margin for Q1 2025 came in at 70.13%, up 335212.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.05% (up 189348.0% YoY), and the FY2025 annual result was 0.04%, up 189374.0% from the prior year.
  • EBT Margin rose to 70.13% in Q1 2025 per IPSC's latest filing, from 821.88% in the prior quarter.
  • Over five years, EBT Margin peaked at 70.13% in Q1 2025 and troughed at 32667.68% in Q2 2023.
  • A 4-year average of 7414.95% and a median of 3544.14% in 2022 frame the typical range for EBT Margin.
  • The sharpest annual moves came in 2023 and 2024: EBT Margin slumped 3044920 bps in 2023, then jumped 2862293 bps in 2024.
  • A 4-year view of EBT Margin shows it stood at 6074.86% in 2022, then sank by 147 bps to 15025.0% in 2023, then jumped by 95 bps to 821.88% in 2024, then jumped by 109 bps to 70.13% in 2025.
  • Business Quant data shows IPSC's EBT Margin at 70.13% in Q1 2025, 821.88% in Q4 2024, and 3948.67% in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 6.40%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 41.95%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Century Therapeutics 444.99 Mn 444.99 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2025 70.13%
Dec 31, 2024 -821.88%
Sep 30, 2024 -3,948.67%
Jun 30, 2024 -4,044.75%
Mar 31, 2024 -3,281.99%
Dec 31, 2023 -15,025.00%
Sep 30, 2023 -21,708.11%
Jun 30, 2023 -32,667.68%
Mar 31, 2023 -1,747.44%
Dec 31, 2022 -6,074.86%
Sep 30, 2022 -1,381.47%
Jun 30, 2022 -2,218.48%
Mar 31, 2022 -3,544.14%